BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19450400)

  • 1. Facial acneiform rash associated with sorafenib.
    Fleta-Asín B; Vañó-Galván S; Ledo-Rodríguez A; Truchuelo-Díez M; Jaén-Olasolo P
    Dermatol Online J; 2009 Apr; 15(4):7. PubMed ID: 19450400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erlotinib-induced acneiform rash not affecting previously irradiated skin].
    Eguren C; Domínguez-Fernández I; Santiago-Sánchez-Mateos DI; García-Díez A
    Actas Dermosifiliogr; 2010 Mar; 101(2):186-7. PubMed ID: 20223168
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of treatment with a colloidal oatmeal lotion on the acneform eruption induced by epidermal growth factor receptor and multiple tyrosine-kinase inhibitors.
    Alexandrescu DT; Vaillant JG; Dasanu CA
    Clin Exp Dermatol; 2007 Jan; 32(1):71-4. PubMed ID: 17034418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papulo-pustular eruption during cetuximab treatment.
    Satta R; Cuccuru MA; Pirodda C; Cottoni F
    G Ital Dermatol Venereol; 2008 Feb; 143(1):87-8. PubMed ID: 18833056
    [No Abstract]   [Full Text] [Related]  

  • 5. Follicular drug eruption induced by gefitinib (ZD 1839, iressa): clinical picture correlates with in vitro data of focal epidermal necrosis after epidermal growth factor inhibition in skin cultures.
    Treudler R; Zouboulis CC
    Dermatology; 2005; 211(4):375-6. PubMed ID: 16286753
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous drug eruptions induced by sorafenib: a case series.
    Maddox JS; Kung EF; Petronic-Rosic V; Sethi A
    J Drugs Dermatol; 2008 Sep; 7(9):891-3. PubMed ID: 19112807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acneiform rash.
    Yamamoto DS; Viale PH; Zhao G
    Clin J Oncol Nurs; 2004 Dec; 8(6):654-6. PubMed ID: 15637959
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acneiforme rash in woman with pulmonary adenocarcinoma].
    Navarro Martín M; Rodríguez Sánchez C; Delgado Fernández C; Mezquita Pérez L; Cruz Hernández JJ
    Rev Clin Esp; 2008 May; 208(5):251-2. PubMed ID: 18457638
    [No Abstract]   [Full Text] [Related]  

  • 9. Fulminant acneiform eruptions after administration of dovitinib in a patient with renal cell carcinoma.
    Hsiao YW; Lin YC; Hui RC; Yang CH
    J Clin Oncol; 2011 Apr; 29(12):e340-1. PubMed ID: 21263088
    [No Abstract]   [Full Text] [Related]  

  • 10. Image Gallery: Sorafenib-induced acne of the buttocks.
    Kiritsi D; Arnold AW
    Br J Dermatol; 2017 Dec; 177(6):e351. PubMed ID: 29313937
    [No Abstract]   [Full Text] [Related]  

  • 11. Eruptive keratoacanthoma-type squamous cell carcinomas in patients taking sorafenib for the treatment of solid tumors.
    Smith KJ; Haley H; Hamza S; Skelton HG
    Dermatol Surg; 2009 Nov; 35(11):1766-70. PubMed ID: 19660024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acneiform eruptions caused by various second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia.
    Jung YS; Kim M; Lee JH; Kim DW; Park HJ
    Br J Dermatol; 2016 Feb; 174(2):456-8. PubMed ID: 26399382
    [No Abstract]   [Full Text] [Related]  

  • 13. Sirolimus-induced acneiform eruption.
    Kunzle N; Venetz JP; Pascual M; Panizzon RG; Laffitte E
    Dermatology; 2005; 211(4):366-9. PubMed ID: 16286750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous effects related to the use of tyrosine kinase inhibitors].
    Mateus C
    Rev Pneumol Clin; 2007 Jan; 63(1 Pt 2):2S16-7. PubMed ID: 17242640
    [No Abstract]   [Full Text] [Related]  

  • 15. A comedonal acneiform eruption following dovitinib therapy.
    Gracia-Cazaña T; Pastushenko I; Concellón MA; Grasa-Jordán MP
    Clin Exp Dermatol; 2014 Oct; 39(7):842-3. PubMed ID: 25196373
    [No Abstract]   [Full Text] [Related]  

  • 16. Dermatologic symptoms associated with the multikinase inhibitor sorafenib.
    Robert C; Mateus C; Spatz A; Wechsler J; Escudier B
    J Am Acad Dermatol; 2009 Feb; 60(2):299-305. PubMed ID: 19028406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecule tyrosine kinase inhibitor and depression.
    Quek R; Morgan JA; George S; Butrynski JE; Polson K; Meyer F; Demetri GD; Block SD
    J Clin Oncol; 2009 Jan; 27(2):312-3. PubMed ID: 19064960
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful topical treatment of sorafenib-induced hand-foot skin reaction in a child with hepatocellular carcinoma.
    Hütten M; Lassay L; Sachs B; Deutz P; Mertens R; Baron JM; Merk HF; Ott H
    Pediatr Dermatol; 2009; 26(3):349-50. PubMed ID: 19706105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unilateral acneiform rash in facial palsy].
    Kerob D; Hennequin V; Bousquet G; Behm E; Lebbe C
    Ann Dermatol Venereol; 2010 Nov; 137(11):727-9. PubMed ID: 21074658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facial nodulocystic eruption induced by sorafenib in a patient with hepatocellular carcinoma.
    Duran-Vian C; Gómez-Fernández C; Navarro-Fernández I; Del Cura LR; Alonso-Buznego L; González-Vela MC; González-López MA
    Indian J Dermatol Venereol Leprol; 2020; 86(4):409-411. PubMed ID: 32415051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.